DFDA

Azathioprine (Immunosuppressant)

Treatment for Myocarditis

Typical Dosage: 1-3 mg/kg/day

Effectiveness
55%
Safety Score
30%
Clinical Trials
2
Participants
500

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
Dosage Range
1-3 mg/kg/day
Time to Effect
Weeks to months
Treatment Duration
Months to years
Evidence Quality
LOW
Confidence Score
60%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$1,500
Side Effect Mgmt:$300
Total Annual:$2,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$4,000
Cost per Remission
$6,667
Azathioprine (Immunosuppressant) Outcomes

for Myocarditis

Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+50%
Remission Rate
+30%
Common Side Effects
Nausea/Vomiting
+15%
Bone marrow suppression
+10%
Liver dysfunction
+7%
Increased infection risk
+5%

Sources:

nih.gov
jst.go.jp
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Azathioprine (Immunosuppressant) in Myocarditis

Micophenolate Mofetil Versus Azathioprine in Myocarditis

NCT05237323COMPLETEDPHASE3
View Study
50 participants
INTERVENTIONAL
Moscow, Russia
Started: Oct 1, 2020